Quarterly report · Q2
4538.TEDINET S100PIJ4
Period2022-04-01 → 2022-09-30
Filed2022-11-10
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 50
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥25.4bn | 2022-04-01 → 2022-09-30 | Standalone | Net sales |
| Revenue | ¥49.6bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales (5-year summary) |
| Revenue | ¥25.0bn | 2021-04-01 → 2021-09-30 | Standalone | Net sales |
| Operating income | ¥1.3bn | 2022-04-01 → 2022-09-30 | Standalone | Operating income |
| Operating income | ¥1.3bn | 2021-04-01 → 2021-09-30 | Standalone | Operating income |
| Ordinary income | ¥1.4bn | 2022-04-01 → 2022-09-30 | Standalone | Ordinary income |
| Ordinary income | ¥2.0bn | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.4bn | 2021-04-01 → 2021-09-30 | Standalone | Ordinary income |
| Profit before tax | ¥1.4bn | 2022-04-01 → 2022-09-30 | Standalone | Income before income taxes |
| Profit before tax | ¥1.3bn | 2021-04-01 → 2021-09-30 | Standalone | Income before income taxes |
| Net income | ¥1.0bn | 2022-04-01 → 2022-09-30 | Standalone | Profit loss |
| Net income | ¥1.5bn | 2021-04-01 → 2022-03-31 | Standalone | Net income loss (5-year summary) |
| Net income | ¥1.0bn | 2021-04-01 → 2021-09-30 | Standalone | Profit loss |
| Total assets | ¥71.3bn | at 2022-09-30 | Standalone | Assets |
| Total assets | ¥69.3bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥70.6bn | at 2021-09-30 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥36.1bn | at 2022-09-30 | Standalone | Liabilities |
| Total liabilities | ¥34.8bn | at 2022-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥35.1bn | at 2022-09-30 | Standalone | Net assets |
| Net assets / equity | ¥34.5bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥34.3bn | at 2021-09-30 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥8.7bn | at 2022-09-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥7.3bn | at 2022-03-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥8.7bn | at 2022-09-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥7.3bn | at 2022-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥8.7bn | at 2021-09-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥7.1bn | at 2021-03-31d | Standalone | Cash and cash equivalents |
| Operating cash flow | ¥1.3bn | 2022-04-01 → 2022-09-30 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.5bn | 2021-04-01 → 2022-03-31 | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.9bn | 2021-04-01 → 2021-09-30 | Standalone | Net cash provided by used in operating activities |
| Investing cash flow | −¥386m | 2022-04-01 → 2022-09-30 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.6bn | 2021-04-01 → 2022-03-31 | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥610m | 2021-04-01 → 2021-09-30 | Standalone | Net cash provided by used in investment activities |
| Financing cash flow | ¥434m | 2022-04-01 → 2022-09-30 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.7bn | 2021-04-01 → 2022-03-31 | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥268m | 2021-04-01 → 2021-09-30 | Standalone | Net cash provided by used in financing activities |
| EPS (basic) | ¥116.13 | 2022-04-01 → 2022-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥52.37 | 2022-07-01 → 2022-09-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥169.09 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥119 | 2021-04-01 → 2021-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥56.55 | 2021-07-01 → 2021-09-30d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥30 | 2022-04-01 → 2022-09-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥60 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥30 | 2021-04-01 → 2021-09-30 | Standalone | Dividend paid per share (5-year summary) |
| Equity ratio | 49.3% | at 2022-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 49.8% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 48.7% | at 2021-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 9,451,169 | at 2022-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 9,451,169 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 9,451,169 | at 2021-09-30 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 407
| Item | Context | Value | Unit |
|---|---|---|---|
| Research and development expenses sga | CurrentYTDDuration_NonConsolidatedMember | 643000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の４の７第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2022-11-10 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第100期第２四半期(自 2022年７月１日 至 2022年９月30日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)扶桑薬品工業株式会社 | |
| Company name in english cover page | FilingDateInstant | Fuso Pharmaceutical Industries, Ltd. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 戸 田 幹 雄 | |
| Address of registered headquarter cover page | FilingDateInstant | Text · Plus | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)06-6969-1131(代表) | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)取締役総務本部長(兼)経理部長 髙 橋 貞 雄 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都中央区日本橋本町二丁目４番５号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)03-5203-7101(代表) | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)執行役員営業本部東京第一支店長(兼)東京事務所長松 井 幸 信 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E00953 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 45380 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)扶桑薬品工業株式会社 | |
| Filer name in english | FilingDateInstant | Fuso Pharmaceutical Industries, Ltd. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | false | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte | |
| Current fiscal year start date | FilingDateInstant | 2022-04-01 | |
| Current period end date | FilingDateInstant | 2022-09-30 | |
| Type of current period | FilingDateInstant | Q2 | |
| Current fiscal year end date | FilingDateInstant | 2023-03-31 | |
| Previous fiscal year start date | FilingDateInstant | 2021-04-01 | |
| Comparative period end date | FilingDateInstant | 2021-09-30 | |
| Previous fiscal year end date | FilingDateInstant | 2022-03-31 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of reporting company (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Business risks (text) | FilingDateInstant | Text · Plus | |
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts for operation (text) | FilingDateInstant | Text · Plus | |
| Total number of shares (text) | FilingDateInstant | Text · Plus | |
| Issued shares total number of shares etc (text) | FilingDateInstant | Text · Plus | |
| Class issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)普通株式 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |